DexCom's devices are incredibly valuable to diabetes patients. The company should continue to increase its addressable market. The stock's valuation looks as reasonable as it has in almost three ...

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares are down sharply year to date due to unimpressive financial results -- and some of the ...

What's next for the stock? We take a look at earnings estimates for some clues. Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares are down ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other healthcare stocks. The healthcare industry remains a vital and resilient sector which is ...

Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...

San Diego, CA-based DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against Well Fargo’s other growth stocks. With the interest rate cycle kicking off in the US, stocks that ...

BATU KAWAN: US-based medical device firm Dexcom Inc has officially opened its new manufacturing facility in Batu Kawan, Penang, marking its first offshore manufacturing site outside the United States.

BATU KAWAN: US-based medical devices company Dexcom Inc has officially opened its new manufacturing facility, also its first offshore manufacturing site outside the United States, in Batu Kawan ...